FDA
Bretylium Tosylate
The FDA lists this product in 13 strengths and forms.
Composition
- Active ingredients
- BRETYLIUM TOSYLATE 50MG/ML
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- BRETYLIUM TOSYLATE 50MG/ML · InjectableANDA070134-001 · Discontinued
- BRETYLIUM TOSYLATE 50MG/ML · InjectableANDA071153-001 · Discontinued
- BRETYLIUM TOSYLATE 50MG/ML · InjectableANDA071151-001 · Discontinued
- BRETYLIUM TOSYLATE 50MG/ML · InjectableANDA071152-001 · Discontinued
- BRETYLIUM TOSYLATE 50MG/ML · InjectableThis page
- BRETYLIUM TOSYLATE 50MG/ML · InjectableANDA070891-001 · Discontinued
- BRETYLIUM TOSYLATE 50MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · InjectableNDA019030-001 · Discontinued
- BRETYLIUM TOSYLATE 50MG/ML · InjectableANDA204386-001 · Discontinued
- BRETYLIUM TOSYLATE 50MG/ML · InjectableANDA070119-001 · Discontinued
- BRETYLIUM TOSYLATE 50MG/ML · InjectableANDA070545-001 · Discontinued
- BRETYLIUM TOSYLATE 50MG/ML · InjectableANDA070546-001 · Discontinued
At a glance
- Brand name
- Bretylium Tosylate
- Route
- Injection
- Dosage form
- Injectable
- Applicant
- Hospira
- Status
- Discontinued
- FDA approval
- 16 Apr 1986
- Application
- NDA019033-001